
Mansour Oveissi
Examiner (ID: 18658, Phone: (571)270-3127 , Office: P/2415 )
| Most Active Art Unit | 2415 |
| Art Unit(s) | 2616, 2464, 2415, 2416 |
| Total Applications | 1005 |
| Issued Applications | 795 |
| Pending Applications | 89 |
| Abandoned Applications | 156 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18483472
[patent_doc_number] => 20230210767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/998895
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998895 | PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME | May 17, 2021 | Pending |
Array
(
[id] => 18483472
[patent_doc_number] => 20230210767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/998895
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998895 | PARTICLE CONTAINING LIPID NANOPARTICLES AND METHOD FOR PRODUCING SAME | May 17, 2021 | Pending |
Array
(
[id] => 17420061
[patent_doc_number] => 11253490
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-02-22
[patent_title] => Compositions and methods of treating cognitive impairment
[patent_app_type] => utility
[patent_app_number] => 17/322316
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2063
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322316
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/322316 | Compositions and methods of treating cognitive impairment | May 16, 2021 | Issued |
Array
(
[id] => 17936418
[patent_doc_number] => 11470847
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
[patent_app_type] => utility
[patent_app_number] => 17/321905
[patent_app_country] => US
[patent_app_date] => 2021-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 20351
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17321905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/321905 | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same | May 16, 2021 | Issued |
Array
(
[id] => 18420095
[patent_doc_number] => 20230174556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => COMPOUNDS AS PROTEIN KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/998998
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998998 | COMPOUNDS AS PROTEIN KINASE INHIBITORS | May 13, 2021 | Pending |
Array
(
[id] => 17921011
[patent_doc_number] => 11464232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-11
[patent_title] => Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
[patent_app_type] => utility
[patent_app_number] => 17/316020
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 17
[patent_no_of_words] => 20290
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17316020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/316020 | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same | May 9, 2021 | Issued |
Array
(
[id] => 17124387
[patent_doc_number] => 20210299155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHODS OF MODULATING IMMUNE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/313296
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313296
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313296 | Methods of modulating immune activity | May 5, 2021 | Issued |
Array
(
[id] => 17124381
[patent_doc_number] => 20210299149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/307275
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/307275 | Methods and compositions for treating meibomian gland dysfunction | May 3, 2021 | Issued |
Array
(
[id] => 17065760
[patent_doc_number] => 20210267975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => AMORPHOUS NILOTINIB MICROPARTICLES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/238869
[patent_app_country] => US
[patent_app_date] => 2021-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17238869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/238869 | Amorphous nilotinib microparticles and uses thereof | Apr 22, 2021 | Issued |
Array
(
[id] => 17007218
[patent_doc_number] => 20210238379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => Dendritic Macroporous Hydrogels Prepared By Crystal Templating
[patent_app_type] => utility
[patent_app_number] => 17/231653
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6385
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231653 | Dendritic macroporous hydrogels prepared by crystal templating | Apr 14, 2021 | Issued |
Array
(
[id] => 17124353
[patent_doc_number] => 20210299121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => CETIRIZINE OPHTHALMIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/217760
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17217760
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/217760 | CETIRIZINE OPHTHALMIC COMPOSITIONS | Mar 29, 2021 | Abandoned |
Array
(
[id] => 18449409
[patent_doc_number] => 20230190685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => FORMULATION
[patent_app_type] => utility
[patent_app_number] => 17/995053
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995053 | FORMULATION | Mar 25, 2021 | Abandoned |
Array
(
[id] => 17140143
[patent_doc_number] => 20210308154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Methods and Compositions for Treating Meibomian Gland Dysfunction
[patent_app_type] => utility
[patent_app_number] => 17/210648
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210648 | Methods and Compositions for Treating Meibomian Gland Dysfunction | Mar 23, 2021 | Abandoned |
Array
(
[id] => 18558693
[patent_doc_number] => 11723918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-15
[patent_title] => Solid pharmaceutical tablet
[patent_app_type] => utility
[patent_app_number] => 17/206226
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7355
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206226
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/206226 | Solid pharmaceutical tablet | Mar 18, 2021 | Issued |
Array
(
[id] => 17168675
[patent_doc_number] => 20210322345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => MIDODRINE HYDROCHLORIDE ORAL SOLUTION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/202238
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/202238 | MIDODRINE HYDROCHLORIDE ORAL SOLUTION AND USES THEREOF | Mar 14, 2021 | Abandoned |
Array
(
[id] => 17306333
[patent_doc_number] => 11207416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Compositions and methods for targeted RNA delivery
[patent_app_type] => utility
[patent_app_number] => 17/192709
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 16
[patent_no_of_words] => 100796
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17192709
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/192709 | Compositions and methods for targeted RNA delivery | Mar 3, 2021 | Issued |
Array
(
[id] => 16898955
[patent_doc_number] => 20210177871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => METHODS FOR CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/188492
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188492
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188492 | Methods for cancer therapy | Feb 28, 2021 | Issued |
Array
(
[id] => 17290799
[patent_doc_number] => 20210386638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => SHAVE-CLEANSER COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/182919
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6968
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/182919 | Shave-cleanser composition | Feb 22, 2021 | Issued |
Array
(
[id] => 17755540
[patent_doc_number] => 11395818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea
[patent_app_type] => utility
[patent_app_number] => 17/180241
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25974
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180241 | Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea | Feb 18, 2021 | Issued |
Array
(
[id] => 18618542
[patent_doc_number] => 11751563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Pathogen eliminating article and methods of manufacturing and using the same
[patent_app_type] => utility
[patent_app_number] => 17/175893
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 8134
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175893
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/175893 | Pathogen eliminating article and methods of manufacturing and using the same | Feb 14, 2021 | Issued |